Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa
- PMID: 25860569
- PMCID: PMC4393239
- DOI: 10.1371/journal.pntd.0003664
Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa
Erratum in
-
Correction: Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa.PLoS Negl Trop Dis. 2015 May 7;9(5):e0003777. doi: 10.1371/journal.pntd.0003777. eCollection 2015 May. PLoS Negl Trop Dis. 2015. PMID: 25950177 Free PMC article. No abstract available.
Abstract
River blindness (onchocerciasis) causes severe itching, skin lesions, and vision impairment including blindness. More than 99% of all current cases are found in sub-Saharan Africa. Fortunately, vector control and community-directed treatment with ivermectin have significantly reduced morbidity. Studies in Mali and Senegal proved the feasibility of elimination with ivermectin administration. The treatment goal is shifting from control to elimination in endemic African regions. Given limited resources, national and global policymakers need a rigorous analysis comparing investment options. For this, we developed scenarios for alternative treatment goals and compared treatment timelines and drug needs between the scenarios. Control, elimination, and eradication scenarios were developed with reference to current standard practices, large-scale studies, and historical data. For each scenario, the timeline when treatment is expected to stop at country level was predicted using a dynamical transmission model, and ivermectin treatment needs were predicted based on population in endemic areas, treatment coverage data, and the frequency of community-directed treatment. The control scenario requires community-directed treatment with ivermectin beyond 2045 with around 2.63 billion treatments over 2013-2045; the elimination scenario, until 2028 in areas where feasible, but beyond 2045 in countries with operational challenges, around 1.48 [corrected] billion treatments; and the eradication scenario, lasting until 2040, around 1.30 billion treatments. The eradication scenario is the most favorable in terms of the timeline of the intervention phase and treatment needs. For its realization, strong health systems and political will are required to overcome epidemiological and political challenges.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures






References
-
- WHO (2007) Global plan to combat neglected tropical diseases, 2008–2015 WHO/CDS/NTD/2007.3. Geneva: WHO; http://whqlibdoc.who.int/hq/2007/WHO_CDS_NTD_2007.3_eng.pdf Accessed on 25 January 2015.
-
- WHO (2012) Accelerating work to overcome the global impact of neglected tropical diseases—a roadmap for implementation. WHO/HTM/NTD/2012.1. http://whqlibdoc.who.int/hq/2012/WHO_HTM_NTD_2012.1_eng.pdf Accessed on 25 January 2015.
-
- UNITING TO COMBAT NTDs (2012) London Declaration on neglected tropical diseases. http://unitingtocombatntds.org/sites/default/files/resource_file/london_... Accessed on 23 May 2014.
-
- WHO (2013) Sustaining the drive to overcome the global impact of neglected tropical diseases—second WHO report on neglected tropical diseases WHO/HTM/NTD/2013.1. Geneva: WHO; http://www.who.int/iris/bitstream/10665/77950/1/9789241564540_eng.pdf Accessed on 25 January 2015.
-
- UNITING TO COMBAT NTDs (2014) Delivering on promises and driving progress. http://unitingtocombatntds.org/resource/delivering-promises-and-driving-... Accessed on 25 January 2015.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources